Video

Evidence-Based Diagnostic and Treatment Practices in ADHD

Jyoti Bhagia, MD, discusses use of a rating scale in diagnosing and treating patients with ADHD.

In this video, Jyoti Bhagia, MD, a child and adolescent psychiatrist at Mayo Clinic, discusses use of a rating scale in diagnosing and treating patients with attention-deficit/hyperactivity disorder (ADHD).

Related Videos
Image credit: K KStock | stock.adobe.com
Image credit: komokvm | stock.adobe.com
Vial of Pneumococcal vaccine - Image credit: Bernard Chantal | stock.adobe.com
Vaccine vials used for Respiratory Syncytial Virus (RSV) with a syringe - Image credit: Peter Hansen | stock.adobe.com
Older patient with medical health checkup with cardiologist or geriatric doctor. Woman with coronary artery heart disease or cardiac illness check-up in clinic - Image credit: Chinnapong | stock.adobe.com
Related Content
Raw vegetables with blood glucose meter, syringe, lancet and stethoscope on desk, diabetes healthy diet concept - Image credit: neirfy | stock.adobe.com
May 29th 2025

Going with the Flow: Updates in Diabetes and Chronic Kidney Disease

Sharon Zhu, PharmD, BCGP, corresponding author Veronica Sozio, PharmD, BCPS Rachel L. Quinn, PharmD, BCACP, AE-C, CDCES
Pharmacy Focus: Navigating Seasonal Allergies
May 28th 2025

Pharmacy Focus: Navigating Seasonal Allergies

Luke Halpern, Assistant Editor Derek Webb, PharmD
vitamins and supplements background - Image credit: MarekPhotoDesign.com | stock.adobe.com
May 29th 2025

Condition Watch: Vitamins

Kennedy Ferruggia, Assistant Editor
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
Infectious viruses such as respiratory syncytial virus (RSV) causing respiratory infections - Image credit: Artur | stock.adobe.com
May 29th 2025

Study Reveals Impact of RSV on the Heart

Kennedy Ferruggia, Assistant Editor
FDA Approves Acoltremon Ophthalmic Solution 0.003% for Signs, Symptoms of Dry Eye Disease
May 28th 2025

FDA Approves Acoltremon Ophthalmic Solution 0.003% for Signs, Symptoms of Dry Eye Disease

Aislinn Antrim, Managing Editor